definiens: ) . WHEREAS, Maxim is developing Maxamine ( as defined below ) in combination with certain drugs for the treatment of certain diseases, and has rights to certain intellectual property related thereto ; WHEREAS, [COMPANY] is developing Pegasys and Ribavirin ( as defined below ) for the treatment of hepatitis C virus and certain cancers ; and WHEREAS, [COMPANY] and Maxim wish to undertake clinical trials and related activities in order to obtain marketing approval of combination therapy with Maxamine, Pegasys and Ribavirin for the treatment of hepatitis C virus and with Maxamine and Pegasys for the treatment of certain cancers, subject to and in accordance with the terms and conditions ofthis Agreement ; and WHEREAS, [COMPANY] and Maxim wish to coordinate sales strategies of Maxamine, Pegasys and Ribavirin in order to facilitate marketing of the combination therapy of such products